Wegovy®
Similar to Ozempic, Wegovy also contains semaglutide but is licensed for weight management. It helps reduce hunger and supports meaningful, long-term fat loss.
- Supports clinically proven weight reduction
- Weekly injection, easy to use

Does Ozempic cause mouth sores? This is a common concern amongst patients prescribed semaglutide for type 2 diabetes management. Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes and reducing cardiovascular risk. Mouth sores are not listed as a recognised side effect in the UK Summary of Product Characteristics, and no established causal link exists based on current clinical evidence. However, indirect factors such as dehydration from gastrointestinal side effects or nutritional changes may contribute to oral symptoms in some individuals. This article examines the evidence, explores potential mechanisms, and provides guidance on when to seek medical advice.
Summary: Ozempic does not directly cause mouth sores according to UK regulatory data, with no established causal link in clinical trials or post-marketing surveillance.
Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and cardiovascular risk reduction in adults with type 2 diabetes who have established cardiovascular disease. Mouth sores are not listed as a side effect in the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA).
It is important to note that there is no established causal link between Ozempic and the development of mouth sores based on current clinical trial data and post-marketing surveillance. However, individual patient experiences vary, and several indirect mechanisms might potentially contribute to oral symptoms in those taking semaglutide. These include gastrointestinal side effects leading to dehydration, reduced food intake potentially affecting nutritional status, or coincidental oral conditions unrelated to the medication.
Patients prescribed Ozempic should be aware that the most frequently reported adverse effects involve the gastrointestinal system, such as nausea, vomiting, and diarrhoea. Mouth sores, if they occur, may be multifactorial and warrant clinical assessment to exclude other causes such as viral infections, nutritional deficiencies (particularly vitamin B12, which can also be associated with metformin use in type 2 diabetes, folate, or iron), or autoimmune conditions. If you develop persistent or troublesome mouth sores whilst taking Ozempic, it is advisable to discuss this with your GP or diabetes specialist nurse to ensure appropriate investigation and management.

Ozempic is generally well tolerated, but like all medicines, it can cause side effects in some individuals. The most commonly reported adverse effects are gastrointestinal in nature and typically occur during the initial weeks of treatment or following dose escalation. According to the SmPC, these include:
Nausea – very common (affecting ≥1 in 10 patients), particularly during titration
Diarrhoea – very common (≥1 in 10 patients)
Vomiting – common (affecting ≥1 in 100 to <1 in 10 patients), which may contribute to dehydration if fluid intake is inadequate
Constipation – common, potentially linked to altered gut motility
Abdominal pain or discomfort – common and usually mild to moderate
Reduced appetite – a therapeutic effect that aids weight loss but may impact nutritional intake
Other recognised side effects include injection site reactions (redness, itching, or swelling), fatigue, dizziness, and headache. Hypoglycaemia (low blood sugar) is uncommon when Ozempic is used alone but may occur if combined with insulin or sulphonylureas. Dose reduction of these medications may be needed to reduce hypoglycaemia risk. Patients should be counselled on recognising hypoglycaemic symptoms such as sweating, tremor, confusion, or palpitations.
Serious but rare adverse effects include pancreatitis (severe abdominal pain radiating to the back), gallbladder disease, and diabetic retinopathy complications. Patients with pre-existing diabetic retinopathy should be monitored closely, especially if on insulin, due to the risk of transient worsening with rapid glycaemic improvement. Severe gastrointestinal side effects may lead to dehydration and acute kidney injury in some cases.
The MHRA and the European Medicines Agency (EMA) continue to monitor the safety profile of semaglutide through pharmacovigilance programmes. Patients are encouraged to report any suspected adverse reactions via the Yellow Card Scheme (yellowcard.mhra.gov.uk), which contributes to ongoing drug safety surveillance in the UK.
Although mouth sores are not a documented side effect of Ozempic in the SmPC, several potential indirect mechanisms might hypothetically explain why some patients experience oral ulceration or discomfort during treatment. It's important to understand that these are theoretical explanations rather than established causal pathways.
Dehydration and reduced saliva production may occur secondary to gastrointestinal side effects such as vomiting or diarrhoea. Adequate hydration is essential for maintaining healthy oral mucosa, and dehydration can predispose individuals to dry mouth (xerostomia) and subsequent ulceration. Saliva plays a protective role in the oral cavity, and reduced salivary flow increases susceptibility to minor trauma and infection.
Nutritional considerations represent another plausible factor. Ozempic reduces appetite and delays gastric emptying, which may lead to decreased food intake. However, it's important to note that short-term use is unlikely to cause significant nutritional deficiencies in most patients. Vitamin B12 deficiency is more commonly associated with long-term metformin use in type 2 diabetes patients and should be considered as an alternative explanation. B12, folate, iron, and zinc are particularly important for oral mucosal health, and deficiency in any of these can manifest as recurrent mouth ulcers, glossitis (tongue inflammation), or angular cheilitis (cracks at the corners of the mouth).
Coincidental oral conditions unrelated to Ozempic are common and include aphthous ulcers (mouth ulcers), herpes simplex virus reactivation, or oral lichen planus. It is also worth considering that patients with diabetes are at increased risk of oral health problems, including fungal infections (oral candidiasis) and periodontal disease, which may be mistaken for drug-related side effects. A thorough clinical evaluation is essential to determine the underlying cause of mouth sores in any patient taking Ozempic.
Whilst occasional minor mouth ulcers are common in the general population and often resolve spontaneously within 7–14 days, certain features warrant prompt medical assessment. Patients taking Ozempic should contact their GP or diabetes care team if they experience any of the following:
Persistent mouth sores lasting longer than three weeks without improvement (this requires urgent referral to exclude oral cancer, as per NICE guideline NG12)
Recurrent ulceration with multiple episodes occurring in quick succession
Large or unusually painful ulcers that interfere with eating, drinking, or speaking
Ulcers accompanied by systemic symptoms such as fever, fatigue, weight loss, or night sweats
Red or white patches in the mouth that do not resolve (these may require urgent referral)
Lumps or swellings in the mouth that persist (these may require urgent referral)
Difficulty swallowing or a sensation of food sticking in the throat
Signs of oral infection including white coating on the tongue (possible thrush), severe pain, or foul taste
Red flag symptoms that require urgent medical attention include severe pain unresponsive to simple analgesia, signs of dehydration (reduced urine output, dizziness, confusion), or any suspicion of a serious underlying condition. Patients should not discontinue Ozempic without consulting their prescriber, as abrupt cessation may affect glycaemic control.
Your GP or dentist may perform a clinical examination of the oral cavity and may arrange blood tests to assess for nutritional deficiencies (full blood count, vitamin B12, folate, ferritin) or other underlying conditions such as coeliac disease where appropriate. In some cases, referral to an oral medicine specialist or urgent suspected cancer referral may be necessary, particularly if ulceration is atypical, persistent beyond three weeks, or fails to respond to initial management. Early assessment ensures that treatable causes are identified and that serious pathology is not overlooked.
If you develop mouth sores or oral discomfort whilst taking Ozempic, several practical measures can help alleviate symptoms and promote healing. These strategies focus on maintaining good oral hygiene, optimising hydration and nutrition, and using appropriate symptomatic treatments.
Maintain excellent oral hygiene by brushing teeth gently twice daily with a soft-bristled toothbrush and using an alcohol-free mouthwash. Some people find toothpastes without sodium lauryl sulphate (SLS) less irritating to sensitive oral mucosa, as recommended in NICE Clinical Knowledge Summaries. Regular dental check-ups are important for patients with diabetes, as they are at increased risk of periodontal disease.
Stay well hydrated by drinking plenty of water throughout the day, particularly if experiencing gastrointestinal side effects. Aim for at least 1.5–2 litres daily unless advised otherwise by your healthcare team. Sugar-free chewing gum or saliva substitutes may help if you experience dry mouth.
Optimise nutritional intake despite reduced appetite. Focus on nutrient-dense foods rich in B vitamins, iron, and zinc. Consider a multivitamin supplement if dietary intake is inadequate, but discuss this with your GP or pharmacist first. Avoid foods that may irritate mouth sores, such as spicy, acidic, or very hot items.
Symptomatic relief can be achieved with over-the-counter treatments such as:
Benzydamine mouthwash or spray for pain relief
Protective gels containing hyaluronic acid or carmellose to coat ulcers
Chlorhexidine mouthwash to reduce secondary bacterial infection (use short-term only, typically for 7 days, as it can cause staining and taste disturbance; avoid using within 30 minutes of toothpaste)
Simple analgesia such as paracetamol for pain management
If mouth sores are severe or persistent despite these measures, your GP may prescribe topical corticosteroids (such as hydrocortisone oromucosal tablets or betamethasone soluble tablets as a mouthwash) or investigate for underlying causes. Do not stop taking Ozempic without medical advice, as maintaining good glycaemic control is essential for overall health and may actually improve oral health outcomes in the longer term.
No, there is no established causal link between Ozempic and mouth sores based on current clinical trial data and post-marketing surveillance. Mouth sores are not listed as a side effect in the UK Summary of Product Characteristics approved by the MHRA.
The most common side effects of Ozempic are gastrointestinal, including nausea and diarrhoea (affecting at least 1 in 10 patients), particularly during initial treatment or dose escalation. Vomiting, constipation, and abdominal discomfort are also common.
You should contact your GP if mouth sores persist for longer than three weeks, recur frequently, are unusually large or painful, or are accompanied by systemic symptoms such as fever or difficulty swallowing. Persistent ulceration beyond three weeks requires urgent referral per NICE guidance to exclude serious pathology.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript